The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luger, T. A.
Right arrow Articles by Schauer, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luger, T. A.
Right arrow Articles by Schauer, E.

The Journal of Immunology, Vol 143, Issue 4 1206-1209, Copyright © 1989 by American Association of Immunologists

ARTICLES

IFN-beta 2/IL-6 augments the activity of human natural killer cells

TA Luger, J Krutmann, R Kirnbauer, A Urbanski, T Schwarz, G Klappacher, A Kock, M Micksche, J Malejczyk and E Schauer
Department of Dermatology II, University of Vienna, Austria.

MHC nonrestricted cytotoxic cells play an important role in the killing of tumor cells in vitro and potentially in vivo. The activity of these cells is regulated by several cytokines such as IL-2 and IFN. In the present study we provide first evidence that IL-6 significantly augments the cytotoxic activity of human NK cells. IL-6 is produced by many different cells and is also known as IFN-beta 2, B cell stimulatory factor 2, hybridoma growth factor, hepatocyte-stimulating factor, and 26 kDa protein. IL-6 stimulates the activity of human CD3- NK cells but not that of CD3+ non-MHC-restricted cytotoxic T lymphocytes. As is the case with IL-2, the IL-6-mediated augmented cytotoxicity was a result of a more efficient lysis, but was not caused by an increased effector to target cell binding. Moreover, the effect of IL-6 on NK cell activity was blocked by a mAb directed against IL-2, and IL-6 itself was found to be a potent inducer of IL-2 production in cultured human PBMC. Thus it may be concluded that IL-6 enhances the cytotoxic activity of NK cells via IL-2. This newly recognized property of IL-6, which is produced by almost any cell, may be of importance in host defense against microbes and malignancies and therefore could contribute to improve the adoptive immunotherapy by using lymphokine- activated killer cells.


This article has been cited by other articles:


Home page
 J. Virol.Home page
J. L. VanCott, M. A. Franco, H. B. Greenberg, S. Sabbaj, B. Tang, R. Murray, and J. R. McGhee
Protective Immunity to Rotavirus Shedding in the Absence of Interleukin-6: Th1 Cells and Immunoglobulin A Develop Normally
J. Virol., June 1, 2000; 74(11): 5250 - 5256.
[Abstract] [Full Text]

Home page
 CirculationHome page
M. Noris, E. Daina, S. Gamba, S. Bonazzola, and G. Remuzzi
Interleukin-6 and RANTES in Takayasu Arteritis : A Guide for Therapeutic Decisions?
Circulation, July 6, 1999; 100(1): 55 - 60.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. N. Boyaka, M. Marinaro, R. J. Jackson, S. Menon, H. Kiyono, E. Jirillo, and J. R. McGhee
IL-12 Is an Effective Adjuvant for Induction of Mucosal Immunity
J. Immunol., January 1, 1999; 162(1): 122 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
T. Kanda, J. E. Wilson McManus, R. Nagai, S. Imai, T. Suzuki, D. Yang, B. M. McManus, and I. Kobayashi
Modification of Viral Myocarditis in Mice by Interleukin-6
Circ. Res., May 1, 1996; 78(5): 848 - 856.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.